"Vaccine Research. Call if you want to be on our participant list for future studies."

During the past decade, McGill University Health Centre-Vaccine Study Centre conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "McGill University Health Centre-Vaccine Study Centre" #1 sponsor was "Medicago" with 5 trials, followed by "Pfizer" with 2 trials sponsored, "University of British Columbia" with 2 trials sponsored, "Dalhousie University" with 1 trials sponsored and "ModernaTX, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "McGill University Health Centre-Vaccine Study Centre" #1 collaborator was "PHAC/CIHR Influenza Research Network" with 2 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "IWK Health Centre" with 1 trials as a collaborator, "MCM Vaccines B.V." with 1 trials as a collaborator and "MEDICAL INTERNATIONAL TECHNOLOGIES (MIT CANADA) INC." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "McGill University Health Centre-Vaccine Study Centre" are "RNA Virus Infections" (4 trials), "Respiratory Tract Diseases" (4 trials), "Respiratory Tract Infections" (4 trials), "Virus Diseases" (4 trials) and "Healthy" (1 trials). Many other conditions were trialed in "McGill University Health Centre-Vaccine Study Centre" in a lesser frequency.

Most popular intervention types in "McGill University Health Centre-Vaccine Study Centre" are "Biological" (12 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "30 µg/strain of Quadrivalent VLP Vaccine" (2 trials), "13-valent pneumococcal conjugate vaccine" (1 trials), "15 µg/strain of Quadrivalent VLP Vaccine" (1 trials) and "15 µg/strain of the licensed quadrivalent vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "McGill University Health Centre-Vaccine Study Centre" are 12 trials for "All" genders.

Currently, there are NaN active trials in "McGill University Health Centre-Vaccine Study Centre". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in McGill University Health Centre-Vaccine Study Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in McGill University Health Centre-Vaccine Study Centre, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".